People with schizophrenia from families with no history of the illness were found to harbor eight times more spontaneous mutations than healthy controls.

Scientists trying to link schizophrenia to a few, common genetic mutations may be missing an important cause of the disease.

Online survey examines overall healthcare in mental health settings from the perspective of both people with schizophrenia and psychiatrists.

A medication that works well for one person with schizophrenia often doesn't work well for another. Genetic variations are thought to play a key role in this difference in response.

Forms of a gene known to increase risk for schizophrenia may create an imbalance in brain pathways for dopamine.

Asenapine, a fast-dissolving, sublingual tablet being developed for treatment of schizophrenia, was more effective than placebo and well tolerated in treating patients with acute schizophrenia.

INVEGA (paliperidone) Extended-Release Tablets showed favorable long-term safety and tolerability in schizophrenia treatment.

Findings provide clues for why people with schizophrenia have lower rates of cancer.

Schizophrenia may occur, in part, because of a problem in an intermittent on/off switch for a gene involved in making a key chemical messenger in the brain.